Using immunofluorescence staining technique and a battery of neurobehavioral tests, we verified that TAT‐LBD‐Ngn2 could penetrate the BBB and concentrate at hippocampus to attenuate learning and memory impairments after GCI models in long term, up to 28 days after GCI. The gene discussed is NEUROG2; the disease is memory impairment.